Angiotensin II antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
US6448280B1 · kind B1 · utility
11Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 1995 |
| Grant date | Sep 10, 2002 |
| Priority date | — |
| Expiry date | Jan 5, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of angiotensin II antagonists in treating or preventing the development of disease conditions associated with impaired neuronal conduction velocity, such as diabetic neuropathy, as well as their use in the manufacture of a medicament for use in such treatment. The invention also concerns pharmaceutical compositions containing an angiotensin II antagonist together with one or more other agents known to be of value in treating or preventing the development of disease conditions associated with impaired neuronal conduction velocity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.